within Pharmacolibrary.Drugs.ATC.V;

model V04CX11
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.95,
    Cl             = 0.3333333333333333,
    adminDuration  = 600,
    adminMass      = 0.3,
    adminCount     = 1,
    Vd             = 0.0007,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0007666666666666667,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Lithium chloride is an inorganic salt of lithium used primarily for its mood-stabilizing properties, especially in the treatment of bipolar disorder and recurrent depression. While lithium salts (most commonly lithium carbonate) remain approved and widely used for psychiatric indications, lithium chloride itself is rarely used today due to gastrointestinal side effects but has historical and some investigational use.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adult patients; typical values are derived from available data on lithium salts as direct clinical PK studies for lithium chloride are very limited.</p><h4>References</h4><ol><li><p>Rosenthal, RC, et al., &amp; Davis, LE (1986). Pharmacokinetics of lithium in the dog. <i>Journal of veterinary pharmacology and therapeutics</i> 9(1) 81–87. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2885.1986.tb00015.x&quot;>10.1111/j.1365-2885.1986.tb00015.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3009841/&quot;>https://pubmed.ncbi.nlm.nih.gov/3009841</a></p></li><li><p>Altamura, AC, et al., &amp; Smeraldi, E (1977). Plasma and intracellular kinetics of lithium after oral administration of various lithium salts. <i>European journal of clinical pharmacology</i> 12(1) 59–63. DOI:<a href=&quot;https://doi.org/10.1007/BF00561406&quot;>10.1007/BF00561406</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/902676/&quot;>https://pubmed.ncbi.nlm.nih.gov/902676</a></p></li><li><p>Bhuiyan, P, et al., &amp; Wei, H (2025). Intranasal Delivery of Lithium Salt Suppresses Inflammatory Pyroptosis in the Brain and Ameliorates Memory Loss and Depression-like Behavior in 5XFAD Mice. <i>Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology</i> 20(1) 26–None. DOI:<a href=&quot;https://doi.org/10.1007/s11481-025-10185-7&quot;>10.1007/s11481-025-10185-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/40095208/&quot;>https://pubmed.ncbi.nlm.nih.gov/40095208</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V04CX11;
